Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms

Mulders, Mick N.; Serhan, Fatima; Goodson, James L.; Icenogle, Joseph; Johnson, Barbara W.; Rota, Paul A.

doi:10.1093/infdis/jix077

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms

Published Date:

Jul 01 2017

Publisher's site:

http://dx.doi.org/10.1093/infdis/jix077 New Site Icon

Source:

J Infect Dis. 2017; 216(Suppl 1):S324-S330.

Language:

English

[PDF-1.66 MB]

Details:

Personal Authors:

Mulders, Mick N. ; Serhan, Fatima ; Goodson, James L. ; Icenogle, Joseph ; Johnson, Barbara W. ; ... More ▼

Keywords:

[+]

Pubmed ID:

28838191

Pubmed Central ID:

PMC5853980

Description:

Laboratory networks were established to provide accurate and timely laboratory confirmation of infections, an essential component of disease surveillance systems. The World Health Organization (WHO) coordinates global laboratory surveillance of vaccine-preventable diseases (VPDs), including polio, measles and rubella, yellow fever, Japanese encephalitis, rotavirus, and invasive bacterial diseases. In addition to providing high-quality laboratory surveillance data to help guide disease control, elimination, and eradication programs, these global networks provide capacity-building and an infrastructure for public health laboratories. There are major challenges with sustaining and expanding the global laboratory surveillance capacity: limited resources and the need for expansion to meet programmatic goals. Here, we describe the WHO-coordinated laboratory networks supporting VPD surveillance and present a plan for the further development of these networks.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

001/World Health Organization/International

Main Document Checksum:

[+]

Supporting Files:

	jix077.nxml	text/xml
	jix07701.gif	image/gif
	jix07701.jpg	image/jpeg
	jix07702.gif	image/gif
	jix07702.jpg	image/jpeg

No Related Documents.

You May Also Like:

Using Acute Flaccid Paralysis Surveillance as a Platform for Vaccine-Preventable Disease Surveillance

Personal Author:

Wassilak, Steven G. F.; Williams, Cheryl L.; Murrill, Christopher S.; Dahl, Benjamin A.; Ohuabunwo, Chima; Tangermann, Rudolf H.;

Published:

Jul 01 2017

Source:

J Infect Dis. 2017; 216(Suppl 1):S293-S298.

Description:

Surveillance for acute flaccid paralysis (AFP) is a fundamental cornerstone of the global polio eradication initiative (GPEI). Active surveillance (with visits to health facilities) is a critical strategy of AFP surveillance systems for highly sensit...

File Type:

[PDF - 111.28 KB]
The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory Networks

Personal Author:

Diop, Ousmane M.; Kew, Olen M.; de Gourville, Esther M.; Pallansch, Mark A.;

Published:

Jul 01 2017

Source:

J Infect Dis. 216(Suppl 1):S299-S307.

Description:

The Global Polio Laboratory Network (GPLN) began building in the late 1980s on a 3-tiered structure of 146 laboratories with different and complementary technical and support capacities (poliovirus isolation, molecular strain characterization includi...

File Type:

[PDF - 568.11 KB]
Integrated Serologic Surveillance of Population Immunity and Disease Transmission

Personal Author:

Arnold, Benjamin F.; Scobie, Heather M.; Priest, Jeffrey W.; Lammie, Patrick J.;

Published:

Jul 2018

Source:

Emerg Infect Dis. 24(7):1188-1194.

Description:

Antibodies are unique among biomarkers in their ability to identify persons with protective immunity to vaccine-preventable diseases and to measure past exposure to diverse pathogens. Most infectious disease surveillance maintains a single-disease fo...

File Type:

[PDF - 2.44 MB]
Transition Planning For After Polio Eradication

Personal Author:

Rutter, Paul D.; Hinman, Alan R.; Hegg, Lea; King, Dennis; Sosler, Stephen; Swezy, Virginia; Hussey, Ann-Lee; Cochi, Stephen L.;

Published:

Jul 01 2017

Source:

J Infect Dis. 2017; 216(Suppl 1):S287-S292.

Description:

The Global Polio Eradication Initiative (GPEI) has been in operation since 1988, now spends $1 billion annually, and operates through thousands of staff and millions of volunteers in dozens of countries. It has brought polio to the brink of eradicati...

File Type:

[PDF - 429.14 KB]
Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach

Personal Author:

Goodson, James L.; Alexander, James P.; Linkins, Robert W.; Orenstein, Walter A.;

Published:

October 23 2017

Source:

Expert Rev Vaccines. 16(12):1203-1216

Description:

Introduction: : In 1988, an estimated 350,000 children were paralyzed by polio and 125 countries reported polio cases, the World Health Assembly passed a resolution to achieve polio eradication by 2000, and the Global Polio Eradication Initiative (GP...

File Type:

[PDF - 316.10 KB]